|
Volumn 29, Issue 1-2, 1997, Pages 649-651
|
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients
a a a a a a a a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
C PEPTIDE;
CREATININE;
CYCLOSPORIN A;
GLUCOSE;
HEMOGLOBIN A1C;
HLA ANTIGEN;
METHYLPREDNISOLONE;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLUCOSE BLOOD LEVEL;
GRAFT REJECTION;
HLA MATCHING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
MALE;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RECIPIENT;
ADULT;
ANTILYMPHOCYTE SERUM;
AZATHIOPRINE;
BLOOD GLUCOSE;
C-PEPTIDE;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT SURVIVAL;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
METHYLPREDNISOLONE;
MUROMONAB-CD3;
PANCREAS TRANSPLANTATION;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
|
EID: 0030948330
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00380-6 Document Type: Conference Paper |
Times cited : (13)
|
References (17)
|